Fluorosis (percentage prevalence in permanent teeth) · Children exposed to topical fluoride when under 6 years old; fluorosis assessed in permanent teeth at 6 to 18 years
It is very uncertain whether started toothbrushing with fluoride toothpaste before 4 years… changes fluorosis (percentage prevalence in permanent teeth) compared with started after 4 years (later start) (very low certainty).
1 finding from 1 review
Dental caries · Adult participants in 25 meta-regression studies
The unadjusted meta-regression coefficient for older mean age was 4.324884.
2 findings from 1 review
Mortality rate in children < 5 years of age · mothers delivering in the hospitals
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vegetable consumption behaviour: proportion in the Action Stage of Change (versus Pre-Action) · Edentulous patients aged 45 to 80 years attending dental-student teaching clinics for replacement dentures, Newcastle Dental Hospital, UK
1 finding from 1 review
Fruit consumption behaviour: proportion in the Action Stage of Change (versus Pre-Action) · Edentulous patients aged 45 to 80 years attending dental-student teaching clinics for replacement dentures, Newcastle Dental Hospital, UK
1 finding from 1 review
One‐to‐one dietary interventions undertaken in a dental setting to change dietary behaviour 2012 · Cochrane All outcomes6 weeks after receiving replacement dentures (about 10 weeks after baseline)
At follow-up 75% (22) of the intervention group versus 29% (8) of the control were in the Action Stage of Change for fruit consumption (P<0.001); baseline 20% (6) versus 8% (2). Significant difference between groups.…
1 study · 58 participants
GRADE not reported
Mortality rate in children < 5 years of age · births
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea (three liquid stools in a single day) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Respiratory infections (as measured by trialists) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
All‐cause death (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Diarrhoea (three liquid stools in a single day) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Respiratory infections (as measured by trialists) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
All‐cause death (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Infection or inflammation at individual level as measured by C‐reactive protein (CRP) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Death (between ages 1 and 6 years) · public health programmes to regularly treat all children aged 16 years or less
Multiple doses of deworming drugs showed no clear difference in mortality (between ages 1 and 6 years) compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
CIN3+ associated with HPV16/18 (age 15 to 26 years) · adolescent girls and women aged 15 to 45 years who were HPV16/18 negative before vaccination
The intervention leads to lower CIN3+ associated with HPV16/18 (age 15 to 26 years) (high certainty).
1 finding from 1 review
Intervention not reported
AIS associated with HPV16/18 or 6/11/16/18 (age 15 to 26 years) · adolescent girls and women aged 15 to 45 years who were HPV16/18 negative before vaccination
The intervention probably leads to lower AIS associated with HPV16/18 or 6/11/16/18 (age 15 to 26 years) (moderate certainty).
1 finding from 1 review
Intervention not reported
Any CIN2+ irrespective of HPV type (age 15 to 26 years) · adolescent girls and women aged 15 to 45 years who were HPV16/18 negative before vaccination
The intervention leads to lower any CIN2+ irrespective of HPV type (age 15 to 26 years) (high certainty).
1 finding from 1 review
Intervention not reported
Any CIN3+ irrespective of HPV type (age 15 to 26 years) · adolescent girls and women aged 15 to 45 years regardless of HPV DNA status at baseline
The intervention probably leads to lower any CIN3+ irrespective of HPV type (age 15 to 26 years) (moderate certainty).
1 finding from 1 review
Intervention not reported
Any CIN3+ irrespective of HPV type (age 15 to 26 years), · adolescent girls and women aged 15 to 45 years regardless of HPV DNA status at baseline
The intervention leads to lower any CIN3+ irrespective of HPV type (age 15 to 26 years), (high certainty).
1 finding from 1 review
Intervention not reported
Any AIS irrespective of HPV type (age 15 to 26 years) · adolescent girls and women aged 15 to 45 years regardless of HPV DNA status at baseline
The intervention leads to lower any AIS irrespective of HPV type (age 15 to 26 years) (high certainty).
1 finding from 1 review